Japan’s Largest Drug Wholesalers Seek To Merge By April
This article was originally published in PharmAsia News
Mediceo Paltac Holdings and Alfresa Holdings, Japan's two largest drug wholesalers, have agreed to an April 1 merger. The plan to be announced officially later would have Mediceo's president head the combined company, with Alfresa's president serving as his vice president. Together the two firms account for nearly $40 million in annual sales at the wholesale level. The merger is expected to lead to a consolidation of distribution centers around Japan and a cut in expenses in the sales and general administration areas. (Click here for more - a subscription may be required
You may also be interested in...
Novartis seems to have accepted the fact that the indication granted for Piqray in the EU means there is little scope for the advanced breast cancer drug to be used in markets such as the UK.
Generic OTC paracetamol and ibuprofen pack prices are gradually returning to pre-COVID levels, according to market analysts Wavedata. But a second wave could drive prices back up again.
Latest EU company news: Sanofi grows OTC portfolio in France and Italy with ColdZyme; Germany's WindStar Medical gets UK owners; and France's Ipsen continues to fell effects of COVID-19 on sales.